Table 7. Correlations of haemostatic parameters with selected antropoclinicopathological parameters in patients with BrCa without coexisting diseases (n=53).
| Coagulation assays | TF activity R/P-values | TF concentration R/P-values | TFPI activity R/P-values | TFPI concentration R/P-values | t-PA concentrationR/P-values | PAI-1 concentration R/P-values |
|---|---|---|---|---|---|---|
| Age (years) | 0.0839/0.5883 | 0.0759/0.6245 | –0.1190/0.4417 | 0.3869/0.0238 | 0.2280/0.1366 | –0.1381/0.3713 |
| BMI (kg/m2) | 0.0562/0.7203 | –0.0398/0.8000 | –0.1284/0.4119 | 0.1344/0.3900 | 0.0597/0.7036 | 0.3904/0.0247 |
| Parity | 0.0090/0.9537 | 0.0428/0.7828 | –0.0084/0.9567 | 0.2434/0.1114 | 0.0366/0.8134 | –0.0339/0.8270 |
| Diameter of the tumour (cm) | -0.0358/0.8312 | – 0.4196/0.0168 | 0.0493/0.7690 | –0.0928/0.5797 | 0.1038/0.5351 | –0.0242/0.8853 |
| Histological grading | 0.3850/0.0236 | –0.1272/0.4403 | – 0.4596/0.0081 | –0.1669/0.3097 | 0.0597/0.7179 | 0.1109/0.5017 |
| Addressing nodes | –0.1657/0.2942 | 0.2698/0.0840 | –0.0021/0.9893 | –0.2061/0.1904 | 0.1211/0.4449 | –0.1678/0.2880 |
| Ki67 expression | –0.0550/0.7294 | –0.0491/0.7574 | 0.1395/0.3783 | –0.2141/0.1733 | 0.1984/0.2078 | 0.1002/0.5279 |
| E-cadherin | –0.0114/0.9427 | 0.2021/0.1993 | 0.1030/0.5163 | –0.1335/0.3994 | –0.0496/0.7552 | –0.1792/0.2560 |
| HER2 | –0.0511/0.7480 | 0.0000/1.0000 | 0.1387/0.3811 | 0.0726/0.6477 | 0.0733/0.6447 | 0.1515/0.3383 |
| PR | 0.0264/0.8684 | –0.2029/0.1974 | –0.1819/0.2490 | –0.1660/0.2933 | 0.0237/0.8815 | –0.1133/0.4749 |
| ER | –0.0364/0.8190 | –0.2460/0.0569 | –0.0971/0.5408 | –0.2153/0.1708 | 0.0030/0.9848 | –0.0576/0.7170 |
Abbreviation: Parity, number of full-term pregnancies.
Significant differences are denoted by bold P-values.